Trials / Unknown
UnknownNCT05150301
Study of the Short-term Mortality and Morbidity of Newborns Born at a Gestational Age <32 Weeks of Amenorrhea
Study of the Short-term Mortality and Morbidity of Newborns Born at a Gestational Age <32 Weeks of Amenorrhea Outside a Level III Maternity Hospital in Alsace
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 134 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 32 Weeks
- Healthy volunteers
- Not accepted
Summary
An "outborn" birth is a premature birth that occurs in an unsuitable level center at the end of the child (unlike "inborn" births). This study aims to describe the morbidity and mortality of very premature newborns (gestational age less than 32 weeks of amenorrhea) born outside a maternity hospital of appropriate level between January 1, 2016 and December 31, 2020, and assessment of the preventable or non-preventable nature of these so-called "outborn" births. The aim of this research is to write down the short-term mortality and morbidity of newborns born at a gestational age \<32 weeks of amenorrhea outside a level III maternity hospital in Alsace between January 1, 2016 and December 31, 2020.
Conditions
Timeline
- Start date
- 2021-11-01
- Primary completion
- 2022-10-01
- Completion
- 2022-10-30
- First posted
- 2021-12-09
- Last updated
- 2021-12-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05150301. Inclusion in this directory is not an endorsement.